Alzheimer's Disease News and Research

RSS
Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.
Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Engineered adeno-associated virus vector yields high transduction of the brain vasculature

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

Small molecule inhibitor of the NLRP3 inflammasome for treating autoinflammatory diseases

The most recent neuroimaging procedures and machine learning approaches for the prediction of Alzheimer’s progression

The most recent neuroimaging procedures and machine learning approaches for the prediction of Alzheimer’s progression

41% of people with post-viral syndrome had evidence of SARS-CoV-2 exposure

41% of people with post-viral syndrome had evidence of SARS-CoV-2 exposure

New study to investigate link between agricultural fire smoke and dementia risk

New study to investigate link between agricultural fire smoke and dementia risk

New digital biomarker could detect Alzheimer's disease in its earliest stages

New digital biomarker could detect Alzheimer's disease in its earliest stages

UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

UT Health San Antonio and partners secure NIH funding to translate scientific discoveries into therapeutic benefits

Max Planck Florida receives NIH funding to investigate the neural circuits underlying Alzheimer's disease

Max Planck Florida receives NIH funding to investigate the neural circuits underlying Alzheimer's disease

Study shows link between regulatory T cells and anxiety, depression, Alzheimer's disease

Study shows link between regulatory T cells and anxiety, depression, Alzheimer's disease

Genetically diverse mouse models offer new insights into Alzheimer's disease

Genetically diverse mouse models offer new insights into Alzheimer's disease

The relationship between breast milk feeding and infants’ neurodevelopment via epigenetics

The relationship between breast milk feeding and infants’ neurodevelopment via epigenetics

Platelets play a role in mediating the rejuvenating effects of exercise during physiological brain ageing

Platelets play a role in mediating the rejuvenating effects of exercise during physiological brain ageing

The growing role of AI in science and discovery

The growing role of AI in science and discovery

Time-restricted feeding may correct the circadian disruptions in Alzheimer's disease

Time-restricted feeding may correct the circadian disruptions in Alzheimer's disease

Sleep dysfunction is underreported and underrecognized in Huntington's disease

Sleep dysfunction is underreported and underrecognized in Huntington's disease

Is there an association between sleep-disordered breathing and Alzheimer's disease?

Is there an association between sleep-disordered breathing and Alzheimer's disease?

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Exploring developmental pathways and disease interactions in nervous and stomatognathic systems

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Medications for chronic diseases can impair thermoregulation, especially in hot weather

Study provides insight into aging of the brain

Study provides insight into aging of the brain

New study offers preliminary estimates of mortality risk by stage in Alzheimer's disease

New study offers preliminary estimates of mortality risk by stage in Alzheimer's disease

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.